| Net Cash Provided by (Used in) Operating Activities |
$212,513 |
USD |
48% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$131,306 |
USD |
48% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4,381,550 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$80,817 |
USD |
75% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$24,678 |
USD |
-87% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$252,874 |
USD |
9.9% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.25 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$26,669 |
USD |
-0.44% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$299,351 |
USD |
15% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$142,163 |
USD |
-1.4% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$162,864 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$6,611 |
USD |
-1.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$252,874 |
USD |
9.9% |
Q4 2024 |
FY 2024 |